We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ITRM market cap is 20.56M. The company's latest EPS is USD -3.2504 and P/E is -0.47.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 175k | -103k | 41k | 50k | 70k |
| Operating Income | -6.86M | -7.27M | -8.49M | -10.77M | -16.62M |
| Net Income | -29.11M | -4.33M | -9.89M | -12.24M | -3.88M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.27M | 233k | 553k | 195k | 503k |
| Operating Income | -76.16M | -101.83M | -31.57M | -24.34M | -29.12M |
| Net Income | -77.06M | -103.13M | -52.01M | -91.56M | -43.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 71.56M | 66.83M | 58.12M | 51.02M | 39.73M |
| Total Liabilities | 39.01M | 38.83M | 39.16M | 43.89M | 36.3M |
| Total Equity | 32.55M | 28M | 18.96M | 7.13M | 3.43M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 97.87M | 25.75M | 32.79M | 91.51M | 66.83M |
| Total Liabilities | 26.25M | 51.99M | 83.35M | 41.28M | 38.83M |
| Total Equity | 71.62M | -26.24M | -50.56M | 50.23M | 28M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.21M | -18.47M | -9.59M | -17.22M | -26.49M |
| Investing | 9.58M | 13.96M | 5.11M | 9.45M | 9.81M |
| Financing | -2.25M | -1.82M | 235k | 435k | 445k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -75.89M | -78.89M | -54.53M | -15.84M | -18.47M |
| Investing | -8.66M | 40.1M | -11k | -54.6M | 13.96M |
| Financing | 120.84M | -974k | 64.48M | 83.13M | -1.82M |
| Market Cap | 20.56M |
| Price to Earnings Ratio | -0.47 |
| Price to Sales Ratio | 40.91 |
| Price to Cash Ratio | 0.97 |
| Price to Book Ratio | 0.73 |
| Dividend Yield | - |
| Shares Outstanding | 13.44M |
| Average Volume (1 week) | 172.51k |
| Average Volume (1 Month) | 159.6k |
| 52 Week Change | 29.66% |
| 52 Week High | 2.64 |
| 52 Week Low | 0.622 |
| Spread (Intraday) | 0.31 (17.61%) |
| Company Name | Iterum Therapeutics PLC |
| Address |
200 s wacker drive chicago, illinois IL 60606 |
| Website | https://www.iterumtx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
